| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net sales | $13K | — | — | — |
| Cost of goods sold | $7K | — | — | — |
| Gross profit | $7K | — | — | — |
| Research and development | $3.4M+44.1% | $2.4M-21.4% | $3.0M | — |
| Selling, general and administrative | $9.5M-13.0% | $10.9M+373.7% | $2.3M | — |
| Total operating expenses | $12.9M-2.8% | $13.3M+149.5% | $5.3M+489.4% | $904K |
| Operating loss | -$12.9M+2.8% | -$13.3M-149.9% | -$5.3M | — |
| Change in fair value of derivative liabilities | -$28.3M-330.1% | $12.3M | — | — |
| Loss on issuance of common stock and warrants | -$31.0M | — | — | — |
| Interest income | $19K+38.3% | $14K | — | $6K |
| Interest expense | -$109K+70.3% | -$367K | — | — |
| Other income (expense) | $258K+4439.6% | -$6K-205.1% | -$2K | — |
| Total other expense | -$28.1M-46.9% | -$19.1M-982804.7% | -$2K-100.1% | $1.8M |
| Net loss before provision for income taxes | -$41.0M-26.5% | -$32.4M-508.8% | -$5.3M-670.2% | $934K |
| Provision for income taxes | — | — | — | $340K |
| Net loss | -$41.0M-26.5% | -$32.4M-508.8% | -$5.3M-996.5% | $594K |
| Weighted average number of shares of common stock outstanding – basic and diluted (in Shares) | 3.9M+92.3% | 2.1M-97.1% | 69.8M+608.9% | 9.8M |
| Weighted average number of shares of common stock outstanding, Diluted (in Shares) | 3.9M+92.3% | 2.1M-97.1% | 69.8M+608.9% | 9.8M |
| Basic and diluted net loss per share of common stock (in Dollars per share) | -$10.39+34.2% | -$15.80-19650.0% | -$0.08-260.0% | $0.05 |
| Diluted net loss per share of common stock (in Dollars per share) | -$10.39+34.2% | -$15.80-19650.0% | -$0.08-260.0% | $0.05 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.